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Abstract 
We describe the case of a patient with cutaneous diphtheria caused by toxigenic Corynebacterium 
ulcerans who developed a right hand flexor sheath infection and symptoms of sepsis such as fever, 
tachycardia, and elevated C-reactive protein, after contact with domestic cats and dogs, and a fox. 
We summarise the epidemiology, clinical presentation, microbiology, diagnosis, therapy, and public 
health aspects of this disease, with emphasis on improving recognition. In many European 
countries, C ulcerans has become the organism commonly associated with cutaneous diphtheria, 
usually seen as an imported tropical disease or resulting from contact with domestic and agricultural 
animals. Diagnosis relies on bacterial culture and confirmation of toxin production, with 
management requiring appropriate antimicrobial therapy and prompt administration of antitoxin, if 
necessary. Early diagnosis is essential for implementation of control measures and clear guidelines 
are needed to assist clinicians in managing clinical diphtheria. This case was a catalyst to the 
redrafting of the 2014 national UK interim guidelines for the public health management of 
diphtheria, released as fi nal guidelines in March, 2015.  
Introduction 
Cutaneous diphtheria presents as a painful ulcerating lesion at the site of inoculation and is often 
associated with erythema and local oedema; a grey membrane analogous to that present in 
respiratory diphtheria is also occasionally evident. Historically, the most commonly identified 
causative bacterium has been Corynebacterium diphtheriae, first noted in diphtheritic membranes 
by Klebs in 1883,1 but a second species in this genus, Corynebacterium ulcerans, can also cause 
both cutaneous and respiratory diphtheria.2–4 Among toxigenic strains of both these species, 
systemic sequelae can also arise, including myocarditis and peripheral neuropathy; the probability 
of developing these sequelae and their severity are related to the extent of the local (either 
cutaneous or respiratory) diphtheria lesion and the immune status of the patient. Diphtheria 
antitoxin was developed in the late 19th century and a toxoid vaccine was developed in the 1920s. 
Subsequent immunisation programmes in the UK and USA in the 1940s, and inclusion of diphtheria 
vaccine in the WHO Expanded Program on Immunization in May, 1974, have had notable effects 
on reported case numbers.5 However, geopolitical changes beginning in the 1990s have led to 
decreases in vaccine coverage in some regions, particularly in eastern Europe, and have been 
associated with an increase in the incidence of diphtheria worldwide.6,7 In the UK, high coverage 
of diphtheria vaccination has been sustained since the 1990s, at 95% in children,8 yet cases are still 
reported. 
 
We describe a case of cutaneous diphtheria caused by C ulcerans in a UK-born London resident, an 
incident that was a catalyst to the redrafting of the 2014 national UK interim guidelines for the 
public health management of diphtheria in England and Wales, released as final guidelines8 
in March, 2015. In this patient, a necrotising flexor sheath infection necessitated plastic surgical 
debridement and the patient developed symptoms characteristic of sepsis and a rash with 
eosinophilic infiltration on histological examination, but without cardiac or neuropathic 
complications. We review the epidemiology, clinical presentation, microbiology, therapy, and 
public health aspects of this infection, highlighting the importance of continued vigilance for 
cutaneous diphtheria in patients presenting with skin and skin structure infections.  
Case presentation 
A 67-year-old woman presented to the emergency department with a 3 day history of a small non-
traumatic raised nodule on the dorsum of her right hand. She reported a pronounced increase in 
pain, swelling, and redness of her right hand immediately before presentation, and two episodes of 
systemic fever and rigors. She also complained of itching on the volar surface of the ipsilateral 
forearm. Her past medical history included hypothyroidism, for which she was on thyroid 
replacement therapy. She denied any travel history in the preceding 12 months, and before that had 
not visited countries where diphtheria is known to be prevalent. She did report being an avid 
gardener and had an extensive animal contact history, with 16 pet cats (including several feral 
felines that she had rehomed or fostered), six pet dogs, and contact with a semi-tame fox that 
entered the house for food. She reported feeding and petting the domesticated animals but denied 
direct contact with the fox, or receiving any bites or scratches from any of the animals. Although 
one feline had malignant neoplastic disease, none had been reported with respiratory symptoms or 
cutaneous ulcers. 
 
Physical examination of the patient confirmed deep non-blanching erythema of both the dorsal and 
palmar aspects of the right hand with tense oedema of the tissues and associated tenderness. A 
necrotic lesion at the base of the index finger was noted, but the skin was intact. Blanching, raised 
erythema of the distal right forearm was apparent, which by contrast with the hand, was non-tender 
and itchy, with an appearance consistent with an allergic urticarial response (figure 1). Tachycardia 
(105 beats per min) and fever (38·2°C) were noted, with other physiological observations remaining 
normal. Laboratory blood analysis revealed a raised white blood cell count (10·9 × 10⁶ cells per L), 
with a normal haemoglobin count (123 g/L), platelet count (249 × 10⁹ cells per L), and blood 
clotting parameters. She had an increased concentration of C-reactive protein (186 mg/L), but all 
other laboratory indices including lactate and blood chemical analysis values were within normal 
limits, and the electrocardiogram was normal. Two sets of blood cultures and a swab of the necrotic 
lesion did not yield microbial growth. Radiographs of the affected hand showed no bony injury, but 
evident soft tissue swelling at the base of the right index finger (figure 2). 
 The patient was admitted and treated empirically with cefuroxime and clindamycin, and referred for 
plastic surgical consultation. Findings at surgical exploration were consistent with a flexor sheath 
infection. Two tissue samples from the first exploratory procedure did not reveal any organism on 
direct Gram staining, but subsequently showed growth of Gram-positive rods described as 
diphtheroids (corynebacterium-like), which were not further speciated on presumption of being 
contaminants and were discarded. Specific cultures for mycobacteria and fungi were negative. 
Histopathological analysis of a biopsy sample from the palmar aspect of her right hand showed 
necrotic fat and fibrovascular material (figure 2). A second surgical exploration on the next day 
allowed further local debridement and application of a surgical vacuum dressing. Short-term 
bacterial, mycobacterial, and fungal cultures at this stage yielded no growth. Histopathological 
analysis of the debrided tissue again showed extensive necrosis, whereas, by contrast, a proximal 
right arm skin biopsy in the area of blanching erythema showed viable tissue with an eosinophilic 
infiltrate (figure 2). 
 
During the subsequent 5 days, some clinical improvement in the hand was evident, although 
erythema substantially increased, extending up the right arm to the scapula and to a non-confluent 
patch across the contralateral flank and abdominal wall. She returned to the operating theatre at day 
7, when surgical exploration showed improvement in tissue viability (fi gure 1). Care was continued 
as an outpatient with oral rifampicin and doxycycline, avoiding β-lactam drugs, because of the 
undefined cause for the eosinophilic rash. After discharge, tissue samples taken during the day 7 
exploratory procedure continued to be cultured using selective techniques, including 5 day 
incubation in a brain-heart broth then subculturing for 48 h on horse blood agar. This revealed again 
a pure growth of Gram- positive rods of diphtheroid appearance (fi gure 2). Identification on this 
occasion via a matrix-assisted laser desorption ionisation-time of flight (MALDI-TOF) Biotyper 
(Bruker Daltonik GmbH, Bremen, Germany) showed this isolate to be C ulcerans (figure 2), with a 
relative intensity of matched peaks score of 2·28, suggesting secure genus identification and 
probable species identification. Disc susceptibility testing9 
Showed sensitivity to penicillin, meticillin, erythromycin, tetracycline, fusidic acid, ciprofloxacin, 
rifampicin, trimethoprim, and resistance to clindamycin. At the Public Health England Respiratory 
and Vaccine Preventable Bacteria Reference Unit (RVPBRU; London, UK), the isolate underwent 
confirmatory identification tests (cysteinase positive with an API Coryne [bioMérieux, Marcy 
l’Etoile, France] profile 0111326) and was revealed by PCR to carry the A portion of the diphtheria 
toxin gene.10,11 Phenotypic confirmation of toxin production was shown by the Elek test.12 
Multilocus sequence typing of the isolate showed it to be sequence type 287. 
 
After 21 days of antibiotic therapy (cefuroxime and clindamycin, then doxycycline and rifampicin), 
the patient recovered full functionality in her right hand (figure 1) and her C-reactive protein 
concentration decreased to 23·3 mg/L. The patient could not recall whether she ever had been 
immunised against diphtheria, and serum retrieved at day 7 of the patient’s admission did not reveal 
diphtheria antitoxin (limit of detection <0·016 IU/mL). 
 
Incident control was coordinated by the local unit of the Health Protection Agency (since April, 
2013, renamed Public Health England Health Protection Team) to oversee the ongoing case 
management and public health implications. This included screening for carriage of C ulcerans, 
confirmation of vaccine status, and tetanus, diphtheria, and inactivated polio vaccine immunisation 
where appropriate for the index case, three household contacts, and health-care staff involved in 
invasive procedures. No secondary carriers or cases of diphtheria were identified. Evidence that cats 
and dogs might act as potential reservoirs for this organism13 prompted consideration as to whether 
the contact animals should be swabbed and screened for C ulcerans. Veterinary advice was sought, 
and screening was felt not to be feasible due to the many possible animal contacts and the 
impracticalities of treating any animals thus identified. 
 Review and discussion 
Epidemiology 
After political changes in eastern Europe and central Asia at the end of the 20th century, a 
resurgence in many vaccine preventable diseases, including diphtheria, was reported across these 
countries. For diphtheria, this resurgence resulted in more than 115 000 cases and 3000 deaths in 
post-Soviet Union alone between 1990 and 1997.6 At the beginning of the 21st century, diphtheria 
is still reported with alacrity, and is monitored by the European Diphtheria Surveillance Network 
now under the remit of the European Centre for Disease Prevention and Control.7 Continuing 
transmission is documented in Latvia, Ukraine, and Russia, posing a risk of epidemic diphtheria 
returning to the European Union.7 In North America, the highest incidence has been historically 
documented in states with large populations of Indigenous Americans,5 but a prolonged 
geographical clustering in Vancouver and Seattle dating back to 1985 or earlier has also been 
reported.14 WHO data for 2012 reported 4489 cases worldwide and an estimated 2500 deaths, with 
diphtheria–tetanus–pertussis vaccination coverage estimated to be 83%.15  
 
Historically C diphtheriae has been the most common causative agent of toxigenic diphtheria 
worldwide, although C ulcerans is now reported more often in the UK. Moreover, although 
respiratory diphtheria remains the most common clinical presentation, cutaneous diphtheria 
continues to be reported in many areas of the world. C ulcerans as a cause of cutaneous diphtheria 
has been reported in European countries,16 including France,17 Germany,18–20 Switzerland,21 
and the UK.2,22 Cases have also been reported in other areas of the world including Canada,23 
Japan,24 Brazil,25 and Sweden (imported from west Africa).26  
 
Human beings are the reservoir for C diphtheriae, in particular children,5 and transmission of C 
diphtheriae occurs from person to person, predominantly from the respiratory tract, but occasionally 
from cutaneous lesions or fomites. A chronic carrier state can exist, but antimicrobial therapy 
provides effective clearance. By contrast, the C ulcerans reservoir is thought to be animals. Cases of 
C ulcerans have been reported after consumption of raw dairy products and contact with cattle,2 
pigs,20 and domestic pets.4,17,19,21,24,27 C ulcerans diphtheria person-to- person transmission 
has been proposed,2,28 but has yet to be confirmed. 
Microbiology 
 
Microbiology 
Corynebacteria are Gram-positive rods. Many species from this genus are skin commensals, having 
a role in human body odour formation,29 and act only as opportunistic pathogens.30 
Of the many Corynebacterium species, three can potentially cause diphtheria: C diphtheriae, C 
ulcerans, and Corynebacterium pseudotuberculosis. Although cases caused by non-toxigenic strains 
have been reported,14,31,32 identification of these three species in a relevant clinical sample is not 
sufficient alone to establish pathogenicity because non-toxin-producing strains of these species 
rarely cause disease. Non-toxin-related corynebacterial virulence factors have been proposed, 
including the presence of a complex cell wall structure containing peptidoglycan and an outer 
mycolic acid layer—functionally equivalent to the outer membrane of Gram-negative bacteria.33  
Corynebacteria also have several adherence mechanisms; for C diphtheriae, adherence is 
predominantly through pili.34 Sequencing of C ulcerans has identified similar subunits of adhesive 
pili of the SpaDEF type and other virulence factors including phospholipase D, neuraminidase H, 
and endoglycosidase E.35  
 
The exotoxin, secreted from C diphtheriae and C ulcerans, is associated with classic diphtheria. 
Toxigenic potential is correlated with corynebacteria lysogenisation by a tox+ phage.36 
Sequencing of the toxin gene in C ulcerans isolates has revealed differences from C diphtheriae. 
When assessed with cytotoxicity assays, C ulcerans toxin- containing supernatants were less potent 
than those from C diphtheriae.37 The toxin itself consists of two subunits. Subunit B binds to the 
receptor, proposed as heparin- binding epidermal growth factor,38 and is then endocytosed. The 
acidic endosome environment induces a toxin conformational change, allowing translocation of the 
active A subunit into the cytoplasm, where cytotoxic activity results through ADP-ribosylation of 
elongation factor 2, which inhibits cellular protein synthesis.39 
 
Clinical presentation 
C diphtheriae and C ulcerans can both cause the same range of diseases. Respiratory diphtheria 
presents typically with a sore throat that can progress to a swollen so-called bull neck, with 
oropharyngeal examination revealing a strongly adherent pseudomembrane that can progress to 
cause airway obstruction. By contrast, cutaneous diphtheria is characterised by painful rolled-edge 
ulcers at the site of inoculation, often associated with erythema and local oedema as in this patient. 
A grey membrane analogous to that reported in respiratory diphtheria can also be seen occasionally. 
The low frequency with which cutaneous diphtheria occurs in many areas of the world, combined 
with the potentially wide differential diagnosis for cutaneous ulcers, contributes to misdiagnoses 
and delayed diagnoses of cutaneous diphtheria, thereby reinforcing the need to sample and culture 
all ulcers with a potentially infectious cause when encountered.  
 
Systemic toxin-mediated sequelae (myocarditis or peripheral neuropathy) can occur in up to 15% of 
cases, predominantly in respiratory diphtheria, but also in patients with extensive local cutaneous 
disease. Myocarditis can lead to complete heart block40 and cardiomyopathies,41 and has a high 
fatality rate. Toxin- mediated neuropathies can also occur, affecting 15% of patients with diphtheria 
in one large case series.42 Bulbar dysfunction was reported in 98% of patients, limb weakness in 
70%, and respiratory failure in 20%, with symptoms persisting for a median of 49 days.42 Allergic 
presentation of disease has not been reported; in our case, the patient’s eosinophilic rash was 
present before antimicrobial treatment was started and fluctuated throughout the early course of her 
illness. Although the patient could not specifically recall having ever been vaccinated for 
diphtheria, a widespread diphtheria vaccination programme was introduced in the UK in the 1940s 
and we speculate that the patient might have shown a type 1 hypersensitivity reaction to epitopes of 
the toxin included in early vaccines. 
Diagnosis 
As noted, a wide differential diagnosis exists for cutaneous ulcers, particularly when history of 
travel43 or animal contact exists. Samples should be assessed by culture of potential bacterial, 
fungal, and mycobacterial causes. Histopathological examination of tissue biopsy samples is also 
essential, particularly when patient history might suggest leishmaniasis.44 Discussion with 
medical microbiologists and pathologists assists appropriate laboratory diagnostics in such cases.  
 
The preponderance of commensal corynebacteria on the skin complicates identification of 
pathogenic species when wound samples are analysed, and can further contribute to delayed 
diagnosis. Delineation of C diphtheriae from other corynebacteria has historically been through the 
use of selective agar and other screening tests,45 which allow subdivision to different C diphtheriae 
biotypes (ie, var gravis, mitis, intermedius, or belfanti). If diphtheria selective agars are not used, 
which is common for non- nasopharyngeal samples, confirmation of species within the 
Corynebacterium genus is based on biochemical differences, which historically has been a 
challenge.46 Despite iterative taxonomical changes since 1992 that have made coryneform-like 
bacterial identification more precise,47 these factors have contributed to the misidentification and 
non-identification of C diphtheriae, and particularly of C ulcerans, in cutaneous syndromes 
consistent with diphtheria.  
 
To assist with bacterial identification, new techniques are becoming widely available in clinical 
laboratories; prime among these is mass spectroscopy, predominantly in the form of MALDI-TOF. 
Introduction of this platform has substantially improved the speed of bacterial identification and is 
cost effective in many settings.48 MALDI-TOF has been shown to provide accurate identification 
of both C diphtheriae49 and non-diphtheriae corynebacteria,50,51 
Yet in wider clinical laboratory practice MALDI-TOF might not provide especially reliable 
identification of other Gram- positive bacilli52 and corroboration by a molecular identification 
method might be indicated. In the case presented, use of MALDI-TOF underpinned the diagnosis, 
allowing identification of diphtheroids, which were previously not routinely speciated. 
 Identification of C diphtheriae, C ulcerans, or C pseudotuberculosis from clinical samples must 
then be followed by determination of toxigenic potential, historically with the Elek test.53 
Difficulties with this method are well documented,54 and modifications have been described that 
decrease the test time from 48 h to 16 h.12 However, this still delays formal diagnosis, and PCR-
based genotypic tests (as an adjunct to phenotypic detection) have been developed.11 Previous 
difficulties in detection of toxigenicity by PCR arising from tox gene sequence variation between C 
diphtheriae and C ulcerans55 have been overcome by development of real-time PCR methods that 
detect the tox gene of both species.56 A negative PCR result is particularly useful for the rapid 
exclusion of toxigenicity, preventing the need for further control measures.8 Genotypic laboratory 
methods also have a role in typing for C diphtheriae and C ulcerans, thereby contributing to public 
health disease control. Genotyping has been done by several different methods, but criticisms have 
been widespread.57 Several different genotyping methods have been trialled, but difficulties with 
discriminatory ability and test reproducibility have been reported.57 Clustered, regularly 
interspaced short palindromic repeats and mini-satellites are promising genomic markers for high-
resolution typing schemes, but are not widely used;58 instead multilocus sequence typing might 
now prove the definitive technique to identify C diphtheriae59 and C ulcerans.60  
 
In addition to microbiological investigations, diagnostic tests to search for the sequelae of toxigenic 
diphtheria should be done in confirmed cases. These tests include electrocardiography and 
echocardiography for myocarditic complications, and nerve conduction studies if symptoms suggest 
peripheral neuropathies. Electrocardiographic monitoring can show early indications of incipient 
heart block, whereas nerve conduction studies can show distal motor latencies, which can persist for 
a prolonged period.42 
 
Therapy 
Treatment for diphtheria focuses on antimicrobial therapy and adjunctive antitoxin use. In 
respiratory diphtheria, airway management might be necessary and should be considered early in 
the course of disease. In cutaneous diphtheria, although patients occasionally need surgical 
intervention, assessment should be sought early to decide whether affected tissues might need 
debridement, as was done in this case.  
 
Much of the evidence for antimicrobial therapy in diphtheria derives from studies in the early 
1970s, stemming predominantly from case series of C diphtheriae rather than C ulcerans, and from 
cases of respiratory rather than cutaneous diphtheria. Erythromycin remains the mainstay of 
therapy61 showing substantial in-vitro activity (mini mum inhibitory concentration for var gravis or 
intermedius 0·025–0·05 mg/L; for var mitis 0·5 mg/L).62 Although occasional instances of 
plasmid-mediated resistance have been documented for more than 25 years,63 continuing C 
diphtheriae resistance surveillance has shown erythromycin susceptibility to be generally 
maintained,64 and with few cases of multidrug resistance reported.65 However, antimicrobial 
susceptibility testing on all diphtheria toxin-producing Corynebacterium species is strongly 
recommended. Of note, erythromycin adverse effects include an association with prolonged QT 
syndrome66 and a theoretical concern of potentiation of myocarditis sequelae from diphtheria toxin. 
Therefore, the appropriateness of erythromycin should be carefully considered. Newer macrolides 
have shown minimum inhibitory concentrations similar to that for erythromycin,64 and although no 
large-scale studies on in-vivo efficacy have been reported, case studies have documented success.67 
The main alternative therapy, penicillin, initially generated concerns regarding higher in-vitro 
minimum inhibitory concentrations for C diphtheriae,61,64 
but these concerns were not supported by the findings of a randomised controlled trial in a 
paediatric Vietnamese population. This trial showed no difference in time to membrane resolution 
or bacteriological clearance between penicillin and erythromycin, but noted a faster median time to 
fever resolution with penicillin (27 h vs 46 h with erythromycin).68 
However, with respect to bacterial clearance, macrolides and lincosomides are preferred to 
penicillins in the carrier state. A trial done in the 1970s showed carrier state clearance of 84% with 
benzathine benzylpenicillin, 92% with erythromycin, and 93% with clindamycin.69 
Crucially, in the case presented here, the patient was initially given a cephalosporin and 
clindamycin for suspected necrotising soft tissue infection, yet the disease progressed, and the C 
ulcerans isolate was established to be resistant to clindamycin in vitro. The patient was discharged 
and continued to take rifampicin and doxycycline, to which the isolate was susceptible. 
 
Integral to management of diphtheria, particularly if the risk of toxin-mediated sequelae is high, is 
diphtheria antitoxin.28 The antitoxin neutralises only non-tissue- bound toxin and should therefore 
be given early in the course of the disease, on the basis of clinical suspicion rather than laboratory 
diagnosis. Although the protective effect of this antitoxin was first described for C diphtheriae, 
evidence suggests that this antitoxin also has a role in C ulcerans diphtheria, despite tox genes and 
prophages varying between these two species at the molecular level.70 
However, availability is a major issue for diphtheria antitoxin, with production reliant on equine 
bleeding and antibody harvesting. In 2009, a worldwide survey showed that many European 
countries held no or only expired stock of antitoxin.71 Alternatives to equine-derived 
antitoxin might become available in the future, and a candidate human monoclonal antibody that 
binds to the diphtheria toxin receptor binding domain has recently been described.72 
 
Public Health  
Consistent with UK national guidelines28 current at the time of the case described, the local health 
protection unit was notified and an incident team was convened to oversee the necessary public 
health measures. Implicit for all cases of respiratory or cutaneous diphtheria is the need for contact 
tracing to identify individuals at risk (panel). For human contacts, nasal and pharyngeal swabs and 
samples from any open wounds should be sent for culture testing before starting chemoprophylaxis 
with either parenteral benzathine benzylpenicillin or oral erythromycin. Carriers of a toxigenic 
corynebacteria should be treated and have control measures instigated; if these carriers are 
inpatients, measures should include barrier nursing until two sets of cultures (nasal and pharyngeal, 
and wound where appropriate) taken 24 h after stopping antimicrobial chemotherapy, and again at 
least 24 h later, remain negative.5,8 
 In addition to chemoprophylaxis, vaccination also plays an essential part in managing the public 
health implications of a diphtheria case. Vaccine administration (one booster for individuals 
previously immunised, three monthly low-dose diphtheria-containing vaccines if unimmunised)8 
is not only necessary as a preventive intervention for contact with diphtheria, but also as an adjunct 
to treatment for the index case during convalescence, since natural infection does not always confer 
immunity.2 In C ulcerans diphtheria, as also noted for antitoxin use, tox gene and prophage 
variation between C diphtheriae and C ulcerans makes the effectiveness of vaccination in these 
cases a relative unknown.70 Despite international immunisation programmes, serosurveillance 
studies suggest that about 50% of adults in the UK, Germany, Italy, and Sweden do not have 
protective titres of diphtheria antibody, and this absence of protection increases to more than 70% in 
older-age cohorts.73  
 
As previously reported,1,2 the transition since the 1990s to most diphtheria cases resulting from C 
ulcerans rather than from C diphtheriae, as exemplified in this Grand Round, has necessitated 
changes to the nature of the risk assessment undertaken and demanded clarity as to the public health 
and clinical actions subsequently needed. For cases of C ulcerans diphtheria, identification of 
animal contacts is particularly relevant in view of zoonotic transmission and the potential for animal 
reservoirs. This identification process can be complex, as seen in this case, and specialist advice is 
often needed to help to decide whether, when, and how animals should be sampled. In the UK, this 
advice is obtained from the Animal Health and Veterinary Laboratories Agency, which considers 
various factors including how likely are identified animals to have been the only potential source of 
the infection (in this case, the wild fox was an unknown source), whether swabs from the animals 
can be practically obtained (especially since the person taking the sample risks injury), and the 
animal welfare implications (arising from sampling and forced administration of antimicrobials 
when C ulcerans might be a commensal in many animals). Additionally, the costs of treatment of 
animal contacts might be high and owners cannot be legally required to treat their animals. Strict 
hygiene observance and vaccination of the index case and human contacts, as done in this case, are 
therefore often the mainstay of incident management. Some areas of the world show immunisation 
schedule disturbances due to various causes; the 2015 outbreak in South Africa74 and case in 
Spain75 highlight the need for continued vigilance and action to prevent a resurgence of diphtheria. 
 
Conclusion 
C ulcerans, although less common worldwide than C diphtheriae, is nevertheless an important 
cause of both respiratory and cutaneous diphtheria (as in this case). Although our patient presented 
with distant cutaneous eosinophilic reaction, most likely to toxin dissemination, no classic cardiac 
or peripheral neuropathic complications were noted. The infrequent incidence of diphtheria in many 
developed areas of the world, compared with the frequency of isolation of other Corynebacterium 
species, contributes to potentially delayed and missed diagnoses, particularly of cutaneous disease. 
Therefore, to ensure diphtheria cases are identified appropriately, prudent guidelines would deem 
full speciation of diphtheroids mandatory for Corynebacterium species cultured from patients with 
unusual skin infections, a positive travel history, or recent animal contact. The extent of cutaneous 
diphtheria might be underestimated because many laboratories do not routinely speciate 
Corynebacterium species from wound samples, and cases can resolve from antimicrobial therapy 
given for other bacterial infections. Advances in rapid diagnostics from both proteomic phenotyping 
of bacteria through MALDI-TOF and in genotypic determination of toxin-producing potential 
might contribute to improved diagnostic ability. However, clear communication with the 
microbiological laboratory regarding the clinical differential diagnosis is essential. Although 
antimicrobial therapy remains effective with little evidence of resistance among causative 
organisms, inadequate availability of antitoxin is a serious concern. Advances in synthetic 
monoclonal antibody production might provide future viable alternatives to current equine- based 
production methods. Toxoid vaccination remains effective but worldwide coverage is still not at 
WHO targets. Some areas of the world show immunisation schedule disturbances from various 
causes, thereby increasing worries that the incidence of diphtheria might again rise. 
 
Search Strategy and selection criteria 
We identified citations for this Grand Round by searching PubMed with the terms “diphtheria”, 
“Corynebacterium ulcerans”, and “Corynebacterium diphtheriae” for articles published in English 
between Jan 1, 1990 and Sept 1, 2014. Relevant articles resulting from these searches, and 
important references cited in those articles, were reviewed. 
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Figure 1. Clinical presentation and progression of Corynebacterium ulcerans cutaneous 
diphtheria. 
 
Figure 1: Clinical presentation and progression of Corynebacterium ulcerans cutaneous diphtheria 
(A) Palmar aspect of the hand at time of presentation. (B) Dorsal aspect of hand at time of 
presentation. (C) Ipsilateral forearm with spreading inflammatory response at time of presentation. 
(D) Palmar aspect of hand after surgical debridement of synovial sheath necrotic tissue at 7 days 
after presentation. (E) Palmar aspect of hand at 28 days after presentation and debridement.  
Figure 2. Laboratory and radiographic investigations of Corynebacterium ulcerans cutaneous 
diphtheria.  
 
Figure 2: Laboratory and radiographic investigations of Corynebacterium ulcerans cutaneous 
diphtheria (A) Plain hand radiograph; arrow indicates marked soft tissue swelling but no bony 
destruction. (B) Matrix assisted laser desorption and ionisation time of flight mass spectra from the 
cultured organism (positive y axis represents C ulcerans from patient; negative y axis represents 
reference C ulcerans spectra). (C) Haematoxylin and eosin staining (×100) of the right arm biopsy 
showing perivascular inflammation rich in eosinophils. (D) Gram staining (×100) of C ulcerans 
grown from tissue biopsy. (E) Haematoxylin and eosin staining (×200) of the right hand tissue 
biopsy showing necrotic fi bro-fatty tissue with acute inflammatory cell infiltrate.  
Table 1. Contact tracing in confirmed cases of diphtheria. 
Examples of contacts who should be 
considered for prophylaxis 
Examples of contacts who are unlikely to 
require prophylaxis 
Household contacts 
- who sleep in the house of the index case 
- who share kitchen facilities in the case of 
multiple-occupancy residences such as 
student accommodation 
Friends/relatives who regularly visit the 
house but do not sleep there 
Kissing/sexual contacts School classroom contacts 
Healthcare workers  
- exposed to airway secretions 
- exposed to open wounds in cutaneous cases 
Healthcare staff that have had contact with 
the index case without droplet or wound 
exposure. 
Individuals exposed to confirmed animal 
cases 
Work colleagues 
 
Table 1: Modified from 2015 Public Health England.8 The risk of infection is directly related to the 
duration and closeness of contact with the index case and public health interventions should be 
guided by accurate contact tracing. The incubation period for diphtheria is 10 days. Therefore, close 
contacts should be identified for the 10 day period before onset of symptoms. Chronic carriage 
conditions can exist; if a suspected time of acquisition is identified, close contacts (particularly 
vulnerable individuals) since that time should be identified. Close contacts should be managed by 
microbiological investigation (swab culture), chemoprophylaxis, exclusion (of high-risk 
occupations including food handlers, care workers, and those who work with unimmunised 
children), and immunisation 
